Fujian Green Pine
300132
Yili Chuanning Biotechnology
301301
Shanghai Menon Animal Nutrition Technology
301156
4
Anhui Hyea Aromas
300886
5
Tuoxin Pharmaceutical Group
301089
CN Stock MarketDetailed Quotes
002273 Zhejiang Crystal-optech
- 19.83
- -0.66-3.22%
Market Closed May 15 15:00 CST
27.58BMarket Cap25.72P/E (TTM)
20.36High19.79Low276.39KlotVolume20.34Open20.49Pre Close551.72MTurnover2.04%Turnover Ratio26.76P/E (Static)1.39BShares27.7752wk High2.98P/B26.93BFloat Cap14.2252wk Low22.54Limit Up1.36BShs Float27.77Historical High18.44Limit Down2.78%Amplitude-0.71Historical Low0.30Dividend TTM19.96Avg Price146.11KlotAsk1.51%Div YieldTTM100Lot Size126.42KlotBid
Zhejiang Crystal-optech Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 10.20%1.48B | 23.67%6.28B | 32.69%4.71B | 43.21%2.65B | 53.41%1.35B | 16.01%5.08B | 10.87%3.55B | -1.63%1.85B | -7.35%876.9M | 14.86%4.38B |
| Operating revenue | 10.20%1.48B | 23.67%6.28B | 32.69%4.71B | 43.21%2.65B | 53.41%1.35B | 16.01%5.08B | 10.87%3.55B | -1.63%1.85B | -7.35%876.9M | 14.86%4.38B |
| Other operating revenue | ---- | 3.87%98.15M | ---- | 129.64%81.59M | ---- | 187.22%94.49M | ---- | 222.23%35.53M | ---- | 0.34%32.9M |
| Total operating cost | 5.53%1.25B | 14.81%5.16B | 19.19%3.75B | 27.38%2.25B | 42.88%1.19B | 16.58%4.49B | 14.83%3.15B | 4.49%1.77B | -4.13%831.1M | 12.06%3.85B |
| Operating cost | 4.47%1.07B | 18.04%4.33B | 24.37%3.22B | 39.28%1.92B | 54.14%1.02B | 14.56%3.66B | 10.92%2.59B | -3.06%1.38B | -10.27%663.27M | 10.20%3.2B |
| Operating tax surcharges | 8.58%16.08M | 22.46%58.74M | 36.00%41.24M | 33.08%25.64M | 40.18%14.81M | 39.40%47.97M | 29.01%30.32M | 26.21%19.27M | 37.34%10.57M | -0.16%34.41M |
| Operating expense | -4.01%15.63M | 20.28%85.47M | 9.38%48.45M | 3.25%30.37M | 28.00%16.29M | 40.34%71.05M | 44.68%44.3M | 44.71%29.42M | 27.70%12.72M | 5.89%50.63M |
| Administration expense | 1.27%74.21M | 3.19%365.04M | -7.07%235.66M | -11.93%141.51M | 12.96%73.28M | -1.27%353.76M | 11.49%253.59M | 15.35%160.68M | 9.38%64.87M | 52.64%358.33M |
| Financial expense | 25.94%-17.37M | -23.46%-86.19M | 5.62%-52.82M | -17.91%-48.41M | -242.15%-23.45M | 43.13%-69.81M | 50.65%-55.96M | 36.04%-41.06M | 57.39%-6.85M | -377.30%-122.75M |
| -Interest expense (Financial expense) | -52.02%512.84K | -57.92%1.82M | -5.50%3.43M | -130.60%-854.69K | -24.70%1.07M | -27.22%4.32M | 166.59%3.63M | 392.06%2.79M | 53.66%1.42M | 69.57%5.94M |
| -Interest Income (Financial expense) | 36.23%-11.71M | 15.90%-56.9M | 12.38%-44.09M | 5.50%-32.74M | -1.98%-18.36M | 14.42%-67.66M | 8.71%-50.32M | 8.72%-34.65M | 9.82%-18M | -54.88%-79.07M |
| Research and development | 14.59%96.44M | -3.80%407.79M | -9.44%259.49M | -18.21%177.28M | -2.72%84.17M | 27.12%423.89M | 19.92%286.55M | 39.90%216.74M | 29.49%86.52M | 36.54%333.46M |
| Credit Impairment Loss | -36.57%4.1M | 94.09%-1.21M | 71.79%-6.56M | 56.42%5.15M | -39.29%6.47M | -1,295.54%-20.52M | -444.64%-23.23M | -21.42%3.29M | 402.37%10.66M | -60.96%1.72M |
| Asset Impairment Loss | -53,198.27%-300K | -56.57%-50.42M | -11,790.78%-48.18M | -101.91%-9.44K | -100.11%-562.87 | 16.28%-32.2M | 103.07%412.14K | 165.35%492.94K | 18.98%530.2K | -47.25%-38.46M |
| Other net revenue | -46.15%24.62M | -28.91%56.72M | -70.51%28.71M | -29.70%79.34M | -24.94%45.71M | -16.05%79.78M | 5.69%97.37M | 31.76%112.86M | 18.19%60.9M | -25.39%95.03M |
| Fair value change income | -182.93%-73.44K | 108.43%225.72K | 95.07%-542.16K | 101.85%317.52K | 102.67%88.56K | -107.94%-2.68M | -496.45%-10.99M | -809.84%-17.16M | -1,576.69%-3.32M | -108.96%-1.29M |
| Invest income | -89.52%2.69M | -0.71%14.22M | 33.88%33.94M | -18.07%24.97M | 87.59%25.63M | -73.33%14.32M | -37.93%25.35M | 64.97%30.48M | 46.28%13.67M | -12.43%53.72M |
| -Including: Investment income associates | -103.92%-997.59K | -61.20%9.93M | 4.55%32.24M | -14.65%23.93M | 90.70%25.47M | -51.46%25.6M | -24.21%30.84M | 52.36%28.04M | 43.00%13.36M | -10.85%52.74M |
| Asset deal income | 655.32%9.9M | -196.76%-5.72M | -205.60%-5.47M | -36.94%2.29M | -68.36%1.31M | 933.20%5.91M | 3,615.16%5.18M | 1,874.93%3.63M | 308.19%4.14M | 151.39%572.27K |
| Other revenue | -32.00%8.3M | -13.33%99.62M | -44.84%55.52M | -49.39%46.62M | -65.35%12.2M | 45.90%114.94M | 52.38%100.65M | 49.71%92.12M | -15.74%35.22M | 5.72%78.78M |
| Operating profit | 24.78%253.93M | 77.24%1.18B | 98.04%983.77M | 141.00%485.66M | 90.72%203.49M | 7.58%664.57M | -9.73%496.76M | -28.24%201.52M | -18.60%106.7M | 23.88%617.76M |
| Add:Non operating Income | -27.75%617.75K | 7.34%4.23M | 140.00%2.13M | 59.32%1.23M | 1,140.80%855K | 96.52%3.94M | -45.34%888.49K | -30.31%769.35K | -86.86%68.91K | 17.77%2.01M |
| Less:Non operating expense | -0.31%724.87K | 101.92%5.71M | 308.28%7.53M | 310.37%2.77M | 32.88%727.15K | -35.81%2.83M | -1.46%1.85M | -51.67%673.84K | 90.25%547.23K | 15.12%4.4M |
| Total profit | 24.65%253.82M | 76.72%1.18B | 97.33%978.37M | 140.12%484.12M | 91.70%203.62M | 8.18%665.69M | -9.86%495.81M | -28.13%201.62M | -19.11%106.22M | 23.93%615.37M |
| Less:Income tax cost | 65.19%29.84M | 174.75%132.53M | 121.44%99.23M | 195.53%44.59M | 68.92%18.06M | 138.54%48.24M | -12.37%44.81M | -33.10%15.09M | -8.57%10.69M | -42.79%20.22M |
| Net profit | 20.71%223.98M | 69.07%1.04B | 94.93%879.14M | 135.64%439.53M | 94.25%185.56M | 3.75%617.45M | -9.61%450.99M | -27.69%186.53M | -20.14%95.53M | 29.04%595.15M |
| Net profit from continuing operation | 20.71%223.98M | 69.07%1.04B | 94.93%879.14M | 135.64%439.53M | 94.25%185.56M | 3.75%617.45M | -9.61%450.99M | -27.69%186.53M | -20.14%95.53M | 29.04%595.15M |
| Less:Minority Profit | -55.23%3.12M | -18.30%14.06M | 33.79%17.6M | 41.29%12.87M | 153.51%6.97M | -8.59%17.2M | -30.03%13.15M | -27.22%9.11M | -50.27%2.75M | -1.17%18.82M |
| Net profit of parent company owners | 23.67%220.86M | 71.57%1.03B | 96.77%861.54M | 140.48%426.66M | 92.49%178.58M | 4.15%600.25M | -8.81%437.84M | -27.72%177.42M | -18.68%92.78M | 30.34%576.33M |
| Earning per share | ||||||||||
| Basic earning per share | 23.08%0.16 | 74.42%0.75 | 103.23%0.63 | 138.46%0.31 | 85.71%0.13 | 2.38%0.43 | -11.43%0.31 | -27.78%0.13 | -12.50%0.07 | 23.53%0.42 |
| Diluted earning per share | 23.08%0.16 | 74.42%0.75 | 100.00%0.62 | 138.46%0.31 | 85.71%0.13 | 2.38%0.43 | -11.43%0.31 | -27.78%0.13 | -12.50%0.07 | 23.53%0.42 |
| Other composite income | 94.32%-226.69K | -28.72%-19.24M | -321.75%-1.3M | -234.56%-7.11M | -249.34%-3.99M | -1,122.86%-14.95M | -93.52%587.68K | 34,933.20%5.28M | 58.87%-1.14M | 103.70%1.46M |
| Other composite income of parent company owners | 93.69%-226.69K | 7.48%-14.98M | -1,185.77%-1.9M | -252.27%-6.73M | -218.96%-3.59M | -944.26%-16.19M | -97.49%174.67K | 447.15%4.42M | 59.48%-1.13M | 96.08%-1.55M |
| Other composite income of minority owners | ---- | -441.71%-4.26M | 43.65%593.27K | -143.67%-376.09K | -2,270.43%-401.11K | -58.63%1.25M | -80.47%413.01K | -33.17%861.14K | ---16.92K | --3.01M |
| Total composite income | 23.23%223.75M | 70.07%1.02B | 94.39%877.83M | 125.44%432.42M | 92.37%181.57M | 0.99%602.5M | -11.11%451.58M | -25.65%191.81M | -19.22%94.38M | 41.47%596.61M |
| Total composite income of parent company owners | 26.08%220.63M | 73.76%1.01B | 96.26%859.64M | 130.93%419.93M | 90.94%174.99M | 1.61%584.06M | -10.07%438.01M | -25.53%181.84M | -17.66%91.65M | 42.74%574.78M |
| Total composite income of minority owners | -52.50%3.12M | -46.89%9.8M | 34.09%18.19M | 25.31%12.5M | 140.41%6.57M | -15.49%18.45M | -35.13%13.57M | -27.78%9.97M | -50.58%2.73M | 14.65%21.83M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.